Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Memantine hydrochloride in the treatment of dementia subtypes.

Peng D, Yuan X, Zhu R.

J Clin Neurosci. 2013 Nov;20(11):1482-5. doi: 10.1016/j.jocn.2013.02.041. Epub 2013 Sep 13. Review.

PMID:
24035650
2.

Memantine: pharmacological properties and clinical uses.

Kumar S.

Neurol India. 2004 Sep;52(3):307-9. Review.

3.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003154.

PMID:
12917950
4.

Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.

O'Brien JT, Burns A; BAP Dementia Consensus Group.

J Psychopharmacol. 2011 Aug;25(8):997-1019. doi: 10.1177/0269881110387547. Epub 2010 Nov 18.

PMID:
21088041
5.

Memantine for dementia.

Areosa Sastre A, McShane R, Sherriff F.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003154. Review. Update in: Cochrane Database Syst Rev. 2005;(2):CD003154.

PMID:
15495043
6.

[Treatment of degenerative dementia disorders--who should be treated?].

Hasselbalch SG, Kampmann JP.

Ugeskr Laeger. 2009 Mar 2;171(10):802-5. Danish.

PMID:
19265606
8.

Alzheimer's disease and the glutamate NMDA receptor.

Doraiswamy PM.

Psychopharmacol Bull. 2003 Spring;37(2):41-9. Review.

PMID:
14566213
9.

Memantine for dementia?

[No authors listed]

Drug Ther Bull. 2003 Oct;41(10):73-6. Review.

PMID:
14593973
10.

Memantine for dementia.

McShane R, Areosa Sastre A, Minakaran N.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003154. Review.

PMID:
16625572
11.

Memantine in dementia: a review of the current evidence.

Herrmann N, Li A, Lanctôt K.

Expert Opin Pharmacother. 2011 Apr;12(5):787-800. doi: 10.1517/14656566.2011.558006. Epub 2011 Mar 9. Review.

PMID:
21385152
12.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(1):CD003154. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD003154.

PMID:
12535459
13.

Memantine for dementia.

Areosa SA, Sherriff F, McShane R.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003154.

PMID:
16034889
14.

Treatment effect size of memantine therapy in Alzheimer disease and vascular dementia.

Smith M, Wells J, Borrie M.

Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3):133-7. Review.

PMID:
16917181
15.

Memantine for dementia.

Areosa SA, Sherriff F, McShane R.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003154. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003154.

PMID:
15846650
16.

Randomized controlled trial of memantine in dementia associated with Parkinson's disease.

Leroi I, Overshott R, Byrne EJ, Daniel E, Burns A.

Mov Disord. 2009 Jun 15;24(8):1217-21. doi: 10.1002/mds.22495.

PMID:
19370737
18.

Memantine: a therapeutic approach in treating Alzheimer's and vascular dementia.

Koch HJ, Uyanik G, Fischer-Barnicol D.

Curr Drug Targets CNS Neurol Disord. 2005 Oct;4(5):499-506. Review.

PMID:
16266284
19.

Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias.

Thomas SJ, Grossberg GT.

Clin Interv Aging. 2009;4:367-77. Epub 2009 Oct 12. Review.

20.

Pharmacological treatment of dementia.

Schwarz S, Froelich L, Burns A.

Curr Opin Psychiatry. 2012 Nov;25(6):542-50. doi: 10.1097/YCO.0b013e328358e4f2. Review.

PMID:
22992546

Supplemental Content

Support Center